TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16633780

Group type: EXPERIMENTAL
Intervention: Target blood propofol concentration of 5 microg x ml(‐1) (group 1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Target blood propofol concentration of 6 microg x ml(‐1) (group 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Target blood concentration set at 1.67 times that of the desired C(e) for 1 min, after which it should revert to the desired concentration.
Number of subjects: 36
Study: 12767102

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus placebo
Number of subjects: 630
Study: 10768088

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 2 mg twice daily
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg twice daily
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 6 mg twice daily
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (all doses)
Number of subjects: 303
Study: 9313277

Group type: EXPERIMENTAL
Intervention: 1 mg of lorazepam in addition to standard opioid analgesics
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo in addition to standard opioid analgesics
Number of subjects: 79
Study: 8101583

Group type: EXPERIMENTAL
Intervention: Intra-articular naloxone (0.04 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intravenous naloxone (0.04 mg)
Number of subjects: 22
Study: 2943703

Group type: EXPERIMENTAL
Intervention: ORS plus boiled-rice feeding
Number of subjects: 48

Group type: COMPARATOR
Intervention: ORS alone
Number of subjects: 48
Study: 30341259

Group type: EXPERIMENTAL
Intervention: Telephone follow-up 24 and 72 hours after surgery
Number of subjects: 638

Group type: COMPARATOR
Intervention: Control group (no telephone follow-up)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 638
Study: 27506593

Group type: EXPERIMENTAL
Intervention: Patients with severe dental anxiety (DAS score ≥ 13)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group from the general population
Number of subjects: 76
Study: 24444428

Group type: EXPERIMENTAL
Intervention: SRP and laser treatment (810 nm diode laser using the 'hot tip' technique at ∼ 760 °C)
Number of subjects: 21

Group type: COMPARATOR
Intervention: SRP treatment alone
Number of subjects: 21
Study: 22857018

Group type: EXPERIMENTAL
Intervention: 6-s high-intensity training (HIT) involving 10 × 6-s sprints for 2 weeks
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 6-s high-intensity training (HIT)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normal training routine (control group, N=6, age 36 ± 9 years, weight 82 ± 11 kg, BMI 26 ± 3 kg·m⁻²)
Number of subjects: 6
Study: 19895855

Group type: EXPERIMENTAL
Intervention: Gamma enhancing neurofeedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 18240282

Group type: EXPERIMENTAL
Intervention: VSL#3 (2 sachets once daily for 12 months)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 31
Study: 15731606

Group type: EXPERIMENTAL
Intervention: Intrathecal levobupivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intrathecal ropivacaine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intrathecal levobupivacaine and ropivacaine at doses of 2.5 mg or greater
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intrathecal levobupivacaine and ropivacaine
Number of subjects: 100
Study: 12828793

Group type: EXPERIMENTAL
Intervention: Trans-rich diet supplying 10% energy as trans-18:1
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Oleate diet
Number of subjects: 29

Group type: COMPARATOR
Intervention: Carbohydrate diet
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Trans diet
Number of subjects: 29
Study: 10751234

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet plus dexfenfluramine (Df)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Combined data from both treatments
Number of subjects: 20
Study: 8857882

Group type: EXPERIMENTAL
Intervention: Low to moderate intensity exercise program (stretching, postural control, endurance walking, coordination exercises)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Low to moderate intensity exercise program with obstacle course practice
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Low to moderate intensity exercise program
Number of subjects: 65
Study: 1346171

Group type: EXPERIMENTAL
Intervention: ABCM (adriamycin, BCNU, cyclophosphamide, and melphalan)
Number of subjects: 630

Group type: COMPARATOR
Intervention: Melphalan (M7)
Number of subjects: 630
Study: 6201409

Group type: EXPERIMENTAL
Intervention: Xenon-arc photocoagulation treatment
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control (untreated) eyes
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Treated eyes with peripheral new vessels only
Number of subjects: 107
Study: 30157224

Group type: EXPERIMENTAL
Intervention: Pre‐diagnostic smoking
Number of subjects: 3304

Group type: EXPERIMENTAL
Intervention: Pre‐diagnostic obesity
Number of subjects: 3304
Study: 27301849

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (nCRT) followed by esophagectomy
Number of subjects: 322

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 322
Study: 24240315

Group type: COMPARATOR
Intervention: Moderate neuromuscular block (train-of-four 1-2) using atracurium/mivacurium
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (post-tetanic count 1-2) using high-dose rocuronium
Number of subjects: 24
Study: 22325684

Group type: EXPERIMENTAL
Intervention: PWB training with audio feedback
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (PWB training without audio feedback)
Number of subjects: 38
Study: 20433313

Group type: EXPERIMENTAL
Intervention: 915 MHz microwave ablation
Number of subjects: 39

Group type: COMPARATOR
Intervention: 2450 MHz microwave ablation
Number of subjects: 39
Study: 18417088

Group type: EXPERIMENTAL
Intervention: Radioguided surgery (RGS) with 5 mCi technetium-99m in group 1
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional surgical exploration in group 2
Number of subjects: 33
Study: 16154486

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg once daily for 8 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Simvastatin 20 mg once daily for 8 weeks
Number of subjects: 104
Study: 12195096

Group type: EXPERIMENTAL
Intervention: Verbal Fluency Test with SPECT activation study in depressed suicidal patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Verbal Fluency Test with SPECT activation study in healthy volunteers
Number of subjects: 40
Study: 9527402

Group type: EXPERIMENTAL
Intervention: Biocompatible membrane (BCM)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Bioincompatible membrane (BICM)
Number of subjects: 153
Study: 7887549

Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Plasma infusion
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Plasma exchange or plasma infusion
Number of subjects: 63
Study: 2576203

Group type: COMPARATOR
Intervention: Transdermal mepindolol (BIO TSD)
Number of subjects: 12
Study: 58197

Group type: EXPERIMENTAL
Intervention: 3000 units of vitamin D2 in a capsule weekly
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chupatty flour fortified with vitamin D (6000 units per kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 31059177

Group type: EXPERIMENTAL
Intervention: Progesterone (200 mg twice daily)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 28101592

Group type: EXPERIMENTAL
Intervention: Fludarabine, mitoxantrone and cyclophosphamide (FCM regimen)
Number of subjects: 120
Study: 25901376

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (75%-80% VO2peak, 65%-80% 1RM)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (60%-65% VO2peak, 50%-65% 1RM)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (usual routines)
Number of subjects: 159
Study: 22309243

Group type: EXPERIMENTAL
Intervention: Calcium-enriched mixture (CEM) cement
Number of subjects: 51

Group type: COMPARATOR
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 51
Study: 21608215

Group type: EXPERIMENTAL
Intervention: Bushen Qiangdu Recipe (BSQDR), one dose daily, taken in two portions (morning and evening) for six months.
Number of subjects: 360

Group type: COMPARATOR
Intervention: SIDSM and sulfasalazine, for six months.
Number of subjects: 360
Study: 19648605

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 2112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2112
Study: 17082466

Group type: EXPERIMENTAL
Intervention: Seizure free (SF) group, treated with 0 to 3 antiepileptic drugs (AEDs)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Not seizure free (NSF) group, treated with 1 to 10 AEDs
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: NSF patients experiencing nonterminal seizure remissions
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Presence of lesions on MRI
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Focal slowing on EEG
Number of subjects: 77
Study: 10393137

Group type: EXPERIMENTAL
Intervention: High calcium diet (1180 +/‐ 117 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low calcium diet (502 +/‐ 99 mg)
Number of subjects: 11
Study: 8894059

Group type: EXPERIMENTAL
Intervention: EEG biofeedback pretraining while listening to infant crying
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EEG biofeedback pretraining without stress
Number of subjects: 15

Group type: COMPARATOR
Intervention: No stress management pretraining while listening to crying
Number of subjects: 15
Study: 2071884

Group type: EXPERIMENTAL
Intervention: Temazepam capsule (20 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Temazepam elixir (20 mg)
Number of subjects: 60
Study: 6846703

Group type: EXPERIMENTAL
Intervention: Choledochoduodenostomy after choledochotomy (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: T-tube drainage (Group B)
Number of subjects: 90
Study: 31062029

Group type: EXPERIMENTAL
Intervention: Sleep duration (each additional hour/day)
Number of subjects: 395803

Group type: EXPERIMENTAL
Intervention: Short and long sleep duration
Number of subjects: 395803
Study: 29683824

Group type: EXPERIMENTAL
Intervention: Fiberoptic nasal intubation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Blind insertion/direct laryngoscopy
Number of subjects: 70
Study: 26399611

Group type: EXPERIMENTAL
Intervention: Neuromuscular control (NMC) exercise training programme
Number of subjects: 1564

Group type: COMPARATOR
Intervention: Standard-practice exercise training programme
Number of subjects: 1564
Study: 24470706

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 23041990

Group type: COMPARATOR
Intervention: Decalcified freeze-dried bone allograft alone (control group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Decalcified freeze-dried bone allograft in combination with polylactic acid, polyglycolic acid barrier membrane (test group)
Number of subjects: 12
Study: 19855255

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (Botulinum toxin and Saline)
Number of subjects: 12
Study: 18027674

Group type: EXPERIMENTAL
Intervention: Classic method combined with prunrllae oral solution (group B1)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Classic method (group A1)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (20 normal thyroidea)
Number of subjects: 56
Study: 16153509

Group type: EXPERIMENTAL
Intervention: Doppler echocardiographic evaluation of pulmonary regurgitation
Number of subjects: 100
Study: 12124949

Group type: EXPERIMENTAL
Intervention: IntraCoil stent treatment
Number of subjects: 93
Study: 10202054

Group type: EXPERIMENTAL
Intervention: Banding ligation
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sclerotherapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study: 7486100

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg i.v. bolus followed by continuous infusion of 5 mg/h for 24 h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2278324

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125%
Number of subjects: 90

Group type: COMPARATOR
Intervention: bupivacaine 0.25% plain
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with adrenaline 1.25 micrograms/ml
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.25% with adrenaline 2.5 micrograms/ml
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with adrenaline 1.25 micrograms/ml and fentanyl 50 micrograms
Number of subjects: 90
Study: 30676140

Group type: EXPERIMENTAL
Intervention: Liquid prepackaged diet (Ldiet)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Solid prepackaged diet (Sdiet)
Number of subjects: 30
Study: 29779983

Group type: EXPERIMENTAL
Intervention: Academic detailing (AD)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Mailed quitline materials (MM)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Overall percentage of quitline registrants hearing about the quitline from any pharmacy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Quitline cards and brochures distributed
Number of subjects: 64
Study: 27312989

Group type: EXPERIMENTAL
Intervention: Prescribed exercise group (E): two 10-min walking sessions every second day at an intensity below self-selected speed
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (C): usual care
Number of subjects: 59
Study: 24705442

Group type: EXPERIMENTAL
Intervention: Electronic decision support tool
Number of subjects: 111

Group type: COMPARATOR
Intervention: Memory alone
Number of subjects: 111
Study: 22257557

Group type: EXPERIMENTAL
Intervention: Employability interventions (specific interventions not detailed in the abstract)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 142
Study: 21236746

Group type: EXPERIMENTAL
Intervention: Minimally invasive Watson-Jones approach
Number of subjects: 141

Group type: COMPARATOR
Intervention: Anterolateral approach with anterior hemimyotomy
Number of subjects: 141
Study: 17532826

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU single dose)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16095547

Group type: EXPERIMENTAL
Intervention: Acupuncture care (average of 8 treatments)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Acupuncture care
Number of subjects: 239

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 239
Study: 12240794

Group type: EXPERIMENTAL
Intervention: 36 mg CONCERTA (methylphenidate HCI) after a high-fat breakfast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mg ADDERALL XR (mixed amphetamine salts) after a high-fat breakfast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 36 mg CONCERTA (methylphenidate HCI) after an overnight fast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mg ADDERALL XR (mixed amphetamine salts) after an overnight fast
Number of subjects: 0
Study: 11329107

Group type: EXPERIMENTAL
Intervention: ACE therapy
Number of subjects: 97
Study: 8673477

Group type: EXPERIMENTAL
Intervention: rIFN‐gamma therapy (recombinant human interferon gamma 1b), administered three times weekly for 12 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (from previous study)
Number of subjects: 30

Group type: COMPARATOR
Intervention: rIFN‐gamma (from previous study)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: rIFN‐gamma therapy
Number of subjects: 30
Study: 2313043

Group type: EXPERIMENTAL
Intervention: Biomechanics platform measures of sway
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Videotaped measures of gait
Number of subjects: 43
Study: 762470

Group type: EXPERIMENTAL
Intervention: Learning disabled label applied to girls
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal label applied to girls
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Learning disabled label applied to boys
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal label applied to boys
Number of subjects: 8
Study: 31689748

Group type: EXPERIMENTAL
Intervention: Patient Education and Rehabilitation Program (PERP)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study: 28749175

Group type: EXPERIMENTAL
Intervention: Local anaesthesia to subcutaneous fat level; lidocaine 1‐2 ml
Number of subjects: 157

Group type: COMPARATOR
Intervention: No local anaesthetic
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Local anaesthesia to deltoid muscle level; 3‐5 ml
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Local anaesthesia to subscapularis muscle level; 6‐8 ml
Number of subjects: 157
Study: 24949910

Group type: EXPERIMENTAL
Intervention: Kurasper F
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GrenGloo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transbond XT
Number of subjects: 30
Study: 23797608

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 120

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 120

Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 120
Study: 21889081

Group type: EXPERIMENTAL
Intervention: Haas-type expander
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Hyrax-type expander
Number of subjects: 33
Study: 19184084

Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at various angles (15°, 30°, 45°, 60°, 75°, 90°)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at 45°, 60°, 75°, and 90°
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at 15°
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sub-maximal arm abduction contractions at 30° to 90°
Number of subjects: 12
Study: 17514432

Group type: EXPERIMENTAL
Intervention: WMHM20 (uncooked physically modified cornstarch)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Uncooked cornstarch
Number of subjects: 21
Study: 12954595

Group type: EXPERIMENTAL
Intervention: C-peptide (5 pmol.kg‐1.min‐1) for 120 min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: C-peptide infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study: 11449079

Group type: EXPERIMENTAL
Intervention: Esterified estrogens combined with methyltestosterone (Estratest)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9683204

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times a day
Number of subjects: 743

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Orlistat continued in year 2
Number of subjects: 743

Group type: COMPARATOR
Intervention: Placebo switched to Orlistat in year 2
Number of subjects: 743

Group type: COMPARATOR
Intervention: Placebo continued in year 2
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 743
Study: 7810176

Group type: EXPERIMENTAL
Intervention: Tryptophan supplemented diet (standard diet + 1.5 g tryptophan)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protein-rich diet (35% carbohydrate, 40% protein)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich diet (80% carbohydrate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard diet (60% carbohydrate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meals with different nutrient relation
Number of subjects: 0
Study: 3046854

Group type: EXPERIMENTAL
Intervention: 400 mg aspartame
Number of subjects: 22

Group type: COMPARATOR
Intervention: 135 mg saccharin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Unsweetened beverage
Number of subjects: 22
Study: 30455167

Group type: EXPERIMENTAL
Intervention: Web-based intervention focusing on physical activity (PA) for the first 4 weeks and fruit and vegetable consumption (FVC) for the subsequent 4 weeks.
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 114
Study: 28224926

Group type: EXPERIMENTAL
Intervention: 30-month worksite-based lifestyle program including personalized lifestyle counseling, physical activity tracker, and sit-stand workstation
Number of subjects: 850

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 850
Study: 26303558

Group type: EXPERIMENTAL
Intervention: Thinking Healthy Programme intervention
Number of subjects: 584

Group type: COMPARATOR
Intervention: Enhanced usual care (Control)
Number of subjects: 584

Group type: COMPARATOR
Intervention: Reference group (no prenatal depression)
Number of subjects: 584
Study: 23129048

Group type: EXPERIMENTAL
Intervention: JTK-853 (800, 1,200, or 1,600 mg twice daily or 1,200 mg three times daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: JTK-853
Number of subjects: 24
Study: 21496753

Group type: EXPERIMENTAL
Intervention: Combined student-parent intervention
Number of subjects: 3490

Group type: COMPARATOR
Intervention: Parent intervention
Number of subjects: 3490

Group type: COMPARATOR
Intervention: Student intervention
Number of subjects: 3490

Group type: COMPARATOR
Intervention: Regular curriculum (control condition)
Number of subjects: 3490
Study: 18929284

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (bolus dose of 1 microg kg(‐1) and maintenance of 0.7 microg kg(‐1) hour(‐1))
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Group TD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control for Group S)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control for Group T)
Number of subjects: 80
Study: 16470820

Group type: EXPERIMENTAL
Intervention: Megestrol 160 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15603468

Group type: EXPERIMENTAL
Intervention: donepezil‐plus‐stimulation group (n = 26)
Number of subjects: 54

Group type: COMPARATOR
Intervention: donepezil‐only group (n = 28)
Number of subjects: 54
Study: 11604980

Group type: EXPERIMENTAL
Intervention: Music therapy (30 minutes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Uninterrupted rest period (30 minutes)
Number of subjects: 20